Panmycin: Broad-Spectrum Antibiotic for Effective Bacterial Infection Control

Panmycin

Panmycin

Price from 41.00 $
Product dosage: 250mg
Package (num)Per pillPriceBuy
30$1.38$41.35 (0%)🛒 Add to cart
60$0.99$82.70 $59.50 (28%)🛒 Add to cart
90$0.84$124.04 $75.64 (39%)🛒 Add to cart
120$0.77$165.39 $92.78 (44%)🛒 Add to cart
180$0.71$248.09 $128.08 (48%)🛒 Add to cart
270$0.66$372.13 $178.50 (52%)🛒 Add to cart
360
$0.64 Best per pill
$496.17 $229.93 (54%)🛒 Add to cart
Product dosage: 500mg
Package (num)Per pillPriceBuy
30$1.61$48.41 (0%)🛒 Add to cart
60$1.13$96.81 $67.57 (30%)🛒 Add to cart
90$0.97$145.22 $87.74 (40%)🛒 Add to cart
120$0.89$193.63 $106.90 (45%)🛒 Add to cart
180$0.81$290.44 $146.23 (50%)🛒 Add to cart
270$0.76$435.66 $204.72 (53%)🛒 Add to cart
360
$0.73 Best per pill
$580.89 $262.21 (55%)🛒 Add to cart

Similar products

Panmycin (tetracycline hydrochloride) is a time-tested, broad-spectrum antibiotic belonging to the tetracycline class, widely utilized in clinical practice for its efficacy against a diverse range of gram-positive and gram-negative bacteria, as well as atypical pathogens. It functions by inhibiting bacterial protein synthesis, effectively halting microbial proliferation and enabling the host immune system to clear the infection. This agent is particularly valued in dermatology, respiratory medicine, and for the management of certain sexually transmitted and zoonotic diseases, offering clinicians a reliable therapeutic option when susceptibility is confirmed. Appropriate use, guided by culture and sensitivity testing, ensures optimal patient outcomes while mitigating the risk of resistance development.

Features

  • Active ingredient: Tetracycline hydrochloride 250 mg or 500 mg capsules
  • Broad-spectrum activity against gram-positive and gram-negative bacteria, Rickettsiae, Mycoplasma pneumoniae, Chlamydia, and spirochetal organisms
  • Mechanism: Binds to the 30S ribosomal subunit, inhibiting bacterial protein synthesis
  • Oral formulation with predictable pharmacokinetics
  • Manufactured under strict pharmaceutical quality control standards

Benefits

  • Effectively treats a wide variety of bacterial infections, reducing symptom duration and complication risks
  • Provides a well-established safety and efficacy profile based on decades of clinical use
  • Offers flexible dosing suitable for both adult and pediatric populations (above age 8)
  • Useful in managing acne vulgaris as a long-term anti-inflammatory and antimicrobial agent
  • Cost-effective antibiotic option within its class
  • Can be used for prophylaxis in specific scenarios, such as malaria (in combination with other agents, where applicable)

Common use

Panmycin is commonly prescribed for bacterial infections caused by susceptible organisms. Typical indications include respiratory tract infections (e.g., pneumonia, bronchitis), skin and soft tissue infections, urinary tract infections (though not first-line), acne vulgaris, sexually transmitted infections like chlamydia, and certain zoonotic infections such as Rocky Mountain spotted fever, typhus, and Q fever. It is also used in the management of Helicobacter pylori eradication regimens (as part of combination therapy) and as a prophylactic agent against malaria in regions with tetracycline-sensitive Plasmodium species.

Dosage and direction

Dosage must be individualized based on the type and severity of infection, patient age, renal function, and susceptibility of the causative organisms. For most infections in adults, the usual dose is 500 mg twice daily or 250 mg four times daily. For severe infections, an initial dose of 1 gram followed by 500 mg every 12 hours may be appropriate. For children above 8 years of age, the dose is 25–50 mg/kg/day divided into four equal doses. Administer Panmycin capsules with a full glass of water, at least one hour before or two hours after meals, to maximize absorption. Do not take with dairy products, antacids, or iron supplements, as these can significantly reduce bioavailability. Continue therapy for at least 24–48 hours after symptoms and fever have subsided.

Precautions

Use of tetracyclines such as Panmycin may result in overgrowth of nonsusceptible organisms, including fungi. If superinfection occurs, discontinue the antibiotic and institute appropriate therapy. Tetracyclines can cause permanent tooth discoloration (yellow-gray-brown) and enamel hypoplasia if used during tooth development (last half of pregnancy, infancy, and childhood up to the age of 8 years). They may also cause photosensitivity; patients should be advised to avoid excessive sunlight or artificial UV exposure and to use protective measures. Use with caution in patients with hepatic impairment, and avoid in patients with significant renal dysfunction unless benefits outweigh risks. May reduce the efficacy of oral contraceptives; advise use of alternative contraceptive methods.

Contraindications

Panmycin is contraindicated in individuals with a known hypersensitivity to tetracycline or any component of the formulation. It should not be used during pregnancy, as it may cause harm to the developing fetus, including inhibition of bone growth and discoloration of teeth. Do not administer to children under 8 years of age due to the risk of permanent tooth discoloration and potential effects on bone development. Avoid use in patients with severe hepatic dysfunction unless no alternative therapy is available.

Possible side effect

Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, epigastric distress, and glossitis. Less frequently, dermatological reactions like photosensitivity, maculopapular rash, or exfoliative dermatitis may occur. Esophageal irritation or ulceration has been reported, especially when capsules are taken with insufficient water or at bedtime. Rare but serious adverse effects include pseudotumor cerebri (benign intracranial hypertension), hepatotoxicity, pancreatitis, and blood dyscrasias. Discontinue use if severe side effects or signs of hypersensitivity (e.g., anaphylaxis, urticaria) occur.

Drug interaction

Tetracyclines can interact with several medications. Antacids containing aluminum, calcium, or magnesium, as well as iron preparations, bismuth subsalicylate, and zinc supplements, can chelate tetracycline and markedly reduce its absorption. Oral anticoagulants (e.g., warfarin) may have enhanced effects; monitor prothrombin time closely. Concurrent use with retinoids may increase the risk of pseudotumor cerebri. Tetracyclines may decrease the efficacy of penicillin-class antibiotics by interfering with their bactericidal action. Avoid concomitant administration with methoxyflurane due to increased risk of nephrotoxicity.

Missed dose

If a dose of Panmycin is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not double the dose to make up for a missed one, as this may increase the risk of side effects.

Overdose

Overdose with Panmycin may lead to nausea, vomiting, and diarrhea. In severe cases, it can cause pancreatitis, hepatotoxicity, or blood abnormalities. There is no specific antidote for tetracycline overdose. Management is supportive and symptomatic, including gastric lavage if ingestion was recent and administration of activated charcoal. Hemodialysis is not effective in removing tetracycline due to high protein binding. Maintain hydration and electrolyte balance; monitor hepatic and renal function.

Storage

Store Panmycin capsules at controlled room temperature, 20°–25°C (68°–77°F), in a tightly closed container. Protect from light, moisture, and excessive heat. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging.

Disclaimer

This information is intended for healthcare professionals and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here. The efficacy and safety of Panmycin may vary based on individual patient factors and local resistance patterns.

Reviews

Panmycin has been extensively reviewed in clinical literature over several decades. It is generally regarded as an effective antibiotic for susceptible organisms, with a well-characterized safety profile when used appropriately. Many clinicians appreciate its broad spectrum and utility in specific niches like rickettsial diseases and acne. Criticisms often focus on gastrointestinal side effects, photosensitivity, and the necessity of adherence to administration guidelines to ensure absorption. Resistance patterns have evolved over time, limiting its use as a first-line agent for some indications, but it remains a valuable tool in the antimicrobial arsenal.